It is recommended that sponsor companies should first check what budget they can allocate, and then seek Clinqua Inc. expertise in achieving their goal.

It is an undesirable reality, but the development of pharmaceutical drugs is a costly undertaking. Yet, these costs are necessitated by the substantial investment of both time and resources of the companies in question. It stands to reason that if a company is willing to invest millions of dollars that they would seek individuals and companies that had the professionals, resources, and capacity to minimize overhead costs and the time needed to bring a drug to the market. Any delay or mismanagement has a two-fold effect, namely fiscal instability for the company and its investors, as well as safety issues for the patients. ClinQua Clinical Trials Inc. www.clinqua.com is such a company because they provide expertise in all facets of clinical development, from clinical design, regulatory affairs, data management, monitoring, quality assurance, and economic structuring. They possess all the tools necessary for a company to complete a clinical trial efficiently and safely. Furthermore, Clinqua is one of the first CRO's (contract research organization) that has implemented a new budgeting approach. They can take a project from its inception, and plan a clinical trial that has the ability to meet any reasonable budget that a pharmaceutical sponsor may provide. However, revealing an acceptable budget to a CRO is a new concept, and one that many sponsors may not feel comfortable providing. Nevertheless, the fact remains that if budgeting is not structured or properly planned and regulated, then a company is susceptible to exceeding any projected budget. Sponsor companies and research and development institutions should first check what budget they can allocate, and then seek Clinqua's expertise in achieving that goal.

In any venture, there is serious risk and return analysis that must be reviewed, and in the case of clinical development of a pharmaceutical grade drug, the odds of success are almost insurmountable considering the lengthy process that must be endured. However, this process can be easier, CRO's like Clinqua present an enormous opportunity to ease the burden of clinical investigation, they only require your initiative. Whether or not a sponsor is willing to seek the advice and experience that Clinqua offers is unknown, what is known however is that if they do, their investors and their bottom line, will be smiling.